INVESTOR PRESENTATION
October 2016
OTC: JOEY
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. All statements pertaining to future financial and/or operating results, future events, or future
developments involving Sack Lunch Productions may constitute forward-looking statements. The statements may
be identified by words such as “expect,” “look forward to,” “anticipate,” “intend,” “plan,” “believe,” “seek,”
“estimate,” “will,” “project,” or words of similar meaning. Such statements are based on the current expectations
and certain assumptions of Sack Lunch Productions’ management, of which many are beyond control. These are
subject to a number of risks, uncertainties, and factors, including but not limited to those described in disclosures,
in particular in the chapter Risks in the Annual Report. Should one or more of these risks or uncertainties
materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results,
performance, or achievements of Sack Lunch Productions may (negatively or positively) vary materially from those
described explicitly or implicitly in the relevant forward-looking statement. Sack Lunch Productions neither
intends, nor assumes any obligation, to update or revise these forward-looking statements in light of
developments which differ from those anticipated.
This presentation includes supplemental financial measures that are or may be non-GAAP financial measures.
These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Sack
Lunch Productions net assets and financial positions or results of operations as presented in accordance with IFRS
in its Consolidated Financial Statements. Other companies that report or describe similarly titled financial
measures may calculate them differently. Due to rounding, numbers presented throughout this and other
documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute
figures.
2016 Joey New York | www.botoxlabb.com
Safe Harbor Statement
2
Corporate Overview
32016 Joey New York | www.botoxlabb.com
Joey New York focuses on building Beauty, Wellness and Lifestyle businesses.
 Seek opportunities with talented
teams and profitable business models
 Drive growth by adding quality
management with industry expertise
combined with strategic sales and
marketing talent
Our portfolio strategy is to identify,
acquire, and enhance existing
businesses or new ideas that offer
revolutionary concepts.
Rolling out state-of-the-art, luxury beauty suite (The LABB) focused on
FDA-approved injectable services through acquisition of 4BG LLC
Investment Highlights
42016 Joey New York | www.botoxlabb.com
 Non-binding LOI to acquire 4BG LLC, owner of The Labb Aesthetic Beauty Bar (LABB)
 State-of-the-art luxury beauty suite offering FDA approved injectable services
 $2 million - $5 million revenue per chair
 30% average gross margins and low overhead
 85% repeat business
 3 locations open today (Miami – flagship; Ft. Lauderdale; Daytona Beach)
 Opening additional locations in Florida, Southern California, Las Vegas, Texas, and New
York City area within next 18 months
 Facial aesthetics market expected to grow to $4.6 billion by 2018 (18% CAGR) and
$9.2 billion by 2020, up from $2.1 billion in 2011
 Top two services are Botox Cosmetic injections and soft tissue filler
 LABB uses FDA-approved injectable fillers manufactured by top global companies:
 Experienced management team
 25+ years of beauty industry experience, combined with medical expertise
Key Stock Facts
52016 Joey New York | www.botoxlabb.com
Exchange: Ticker OTC: JOEY
Recent Price $3.50
Shares Outstanding 27.8 million
Float 2.8 million
Market Cap $97.5 million
Data as of October 10, 2016
The LABB
62016 Joey New York | www.botoxlabb.com
First-of-its-kind aesthetic injectables beauty bar.
LeadingFDA-ApprovedProducts
Staffed by expert certified nurse practitioners
trained to design treatments using injectables to
create the perfect look for patients.
Each LABB consists of 1 to 3 chairs, with $2M-$5M
revenue potential per chair.
$9.2 Billion Market Opportunity
72016 Joey New York | www.botoxlabb.com
$0
$2
$4
$6
$8
$10
Facial Aesthetics Market
(in billions USD)
Quick Facts
• Americans spent $13.5+ billion on surgical and nonsurgical procedures in 2015
• Up $1.5 billion from 2014
• Nonsurgical procedures increased 22%
YoY to 10.9M
• Combined surgical and nonsurgical
procedures increased 20% YoY to 12.8M
• Overall injectables increased 21% in 2015
The LABB – Current Locations
82016 Joey New York | www.botoxlabb.com
3 LABB Locations Opened in 2016
 Rave reviews
 Loyal clientele
 Positive media coverage
Miami Beach
 x chairs
 May 2016
Ft. Lauderdale
 x chairs
 September 2016
Daytona Beach
 x chairs
 Summer 2016
The LABB – Rapid Near-Term Expansion
92016 Joey New York | www.botoxlabb.com
Plans to open 17 additional LABB locations by 2018
 Florida (6)
 California (7)
 Las Vegas (1)
 NY/CT (3)
+ 3 current locations
2019
TX & additional West
Coast locations +
launching franchise
program in 2019
Attractive Chair-Level Economics with Low Overhead
102016 Joey New York | www.botoxlabb.com
Revenue per chair based on saturation rates of 40% and 100%
Repeat Customers
Services & Product Sales
Manufacturer Rebates
85%
15%
Revenue Mix
Product & Operating Expense
Operating Margin
Income & Expenses
57%
43% Average Sale per
Patient Visit
Average Patients per
Chair per Day
(80% Saturation)
Revenue per Chair per Week
(80% Saturation; 112 Patients/Week)
Experienced Management Team
112016 Joey New York | www.botoxlabb.com
Joey Chancis
CEO & Founder, Joey New York / Managing Director, The LABB
Danielle Smith, NP-C
CEO & President, 4BG / Chief Aesthetic Officer, The LABB
Richard Roer
President, Joey New York / Managing Director, The LABB
Jennifer Popov
Chief Brand Officer, The LABB
Investment Highlights
122016 Joey New York | www.botoxlabb.com
 Non-binding LOI to acquire 4BG LLC, owner of The Labb Aesthetic Beauty Bar (LABB)
 State-of-the-art luxury beauty suite offering FDA approved injectable services
 $2 million - $5 million revenue per chair
 30% average gross margins and low overhead
 85% repeat business
 3 locations open today (Miami – flagship; Ft. Lauderdale; Daytona Beach)
 Opening additional locations in Florida, Southern California, Las Vegas, Texas, and New
York City area within next 18 months
 Facial aesthetics market expected to grow to $4.6 billion by 2018 (18% CAGR) and
$9.2 billion by 2020, up from $2.1 billion in 2011
 Top two services are Botox Cosmetic injections and soft tissue filler
 LABB uses FDA-approved injectable fillers manufactured by top global companies:
 Experienced management team
 25+ years of beauty industry experience, combined with medical expertise
13
Trump Tower I
16001 Collins Ave, #3202
Sunny Isles Beach, FL 33160
www.joeynewyork.com
OTC: JOEY
Tel: 305-948-9998
Fax: 305-675-2233
info@joeynewyork.com

JOEY - Investor Presentation

  • 1.
  • 2.
    This presentation containsforward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, future events, or future developments involving Sack Lunch Productions may constitute forward-looking statements. The statements may be identified by words such as “expect,” “look forward to,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project,” or words of similar meaning. Such statements are based on the current expectations and certain assumptions of Sack Lunch Productions’ management, of which many are beyond control. These are subject to a number of risks, uncertainties, and factors, including but not limited to those described in disclosures, in particular in the chapter Risks in the Annual Report. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance, or achievements of Sack Lunch Productions may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Sack Lunch Productions neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated. This presentation includes supplemental financial measures that are or may be non-GAAP financial measures. These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Sack Lunch Productions net assets and financial positions or results of operations as presented in accordance with IFRS in its Consolidated Financial Statements. Other companies that report or describe similarly titled financial measures may calculate them differently. Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures. 2016 Joey New York | www.botoxlabb.com Safe Harbor Statement 2
  • 3.
    Corporate Overview 32016 JoeyNew York | www.botoxlabb.com Joey New York focuses on building Beauty, Wellness and Lifestyle businesses.  Seek opportunities with talented teams and profitable business models  Drive growth by adding quality management with industry expertise combined with strategic sales and marketing talent Our portfolio strategy is to identify, acquire, and enhance existing businesses or new ideas that offer revolutionary concepts. Rolling out state-of-the-art, luxury beauty suite (The LABB) focused on FDA-approved injectable services through acquisition of 4BG LLC
  • 4.
    Investment Highlights 42016 JoeyNew York | www.botoxlabb.com  Non-binding LOI to acquire 4BG LLC, owner of The Labb Aesthetic Beauty Bar (LABB)  State-of-the-art luxury beauty suite offering FDA approved injectable services  $2 million - $5 million revenue per chair  30% average gross margins and low overhead  85% repeat business  3 locations open today (Miami – flagship; Ft. Lauderdale; Daytona Beach)  Opening additional locations in Florida, Southern California, Las Vegas, Texas, and New York City area within next 18 months  Facial aesthetics market expected to grow to $4.6 billion by 2018 (18% CAGR) and $9.2 billion by 2020, up from $2.1 billion in 2011  Top two services are Botox Cosmetic injections and soft tissue filler  LABB uses FDA-approved injectable fillers manufactured by top global companies:  Experienced management team  25+ years of beauty industry experience, combined with medical expertise
  • 5.
    Key Stock Facts 52016Joey New York | www.botoxlabb.com Exchange: Ticker OTC: JOEY Recent Price $3.50 Shares Outstanding 27.8 million Float 2.8 million Market Cap $97.5 million Data as of October 10, 2016
  • 6.
    The LABB 62016 JoeyNew York | www.botoxlabb.com First-of-its-kind aesthetic injectables beauty bar. LeadingFDA-ApprovedProducts Staffed by expert certified nurse practitioners trained to design treatments using injectables to create the perfect look for patients. Each LABB consists of 1 to 3 chairs, with $2M-$5M revenue potential per chair.
  • 7.
    $9.2 Billion MarketOpportunity 72016 Joey New York | www.botoxlabb.com $0 $2 $4 $6 $8 $10 Facial Aesthetics Market (in billions USD) Quick Facts • Americans spent $13.5+ billion on surgical and nonsurgical procedures in 2015 • Up $1.5 billion from 2014 • Nonsurgical procedures increased 22% YoY to 10.9M • Combined surgical and nonsurgical procedures increased 20% YoY to 12.8M • Overall injectables increased 21% in 2015
  • 8.
    The LABB –Current Locations 82016 Joey New York | www.botoxlabb.com 3 LABB Locations Opened in 2016  Rave reviews  Loyal clientele  Positive media coverage Miami Beach  x chairs  May 2016 Ft. Lauderdale  x chairs  September 2016 Daytona Beach  x chairs  Summer 2016
  • 9.
    The LABB –Rapid Near-Term Expansion 92016 Joey New York | www.botoxlabb.com Plans to open 17 additional LABB locations by 2018  Florida (6)  California (7)  Las Vegas (1)  NY/CT (3) + 3 current locations 2019 TX & additional West Coast locations + launching franchise program in 2019
  • 10.
    Attractive Chair-Level Economicswith Low Overhead 102016 Joey New York | www.botoxlabb.com Revenue per chair based on saturation rates of 40% and 100% Repeat Customers Services & Product Sales Manufacturer Rebates 85% 15% Revenue Mix Product & Operating Expense Operating Margin Income & Expenses 57% 43% Average Sale per Patient Visit Average Patients per Chair per Day (80% Saturation) Revenue per Chair per Week (80% Saturation; 112 Patients/Week)
  • 11.
    Experienced Management Team 112016Joey New York | www.botoxlabb.com Joey Chancis CEO & Founder, Joey New York / Managing Director, The LABB Danielle Smith, NP-C CEO & President, 4BG / Chief Aesthetic Officer, The LABB Richard Roer President, Joey New York / Managing Director, The LABB Jennifer Popov Chief Brand Officer, The LABB
  • 12.
    Investment Highlights 122016 JoeyNew York | www.botoxlabb.com  Non-binding LOI to acquire 4BG LLC, owner of The Labb Aesthetic Beauty Bar (LABB)  State-of-the-art luxury beauty suite offering FDA approved injectable services  $2 million - $5 million revenue per chair  30% average gross margins and low overhead  85% repeat business  3 locations open today (Miami – flagship; Ft. Lauderdale; Daytona Beach)  Opening additional locations in Florida, Southern California, Las Vegas, Texas, and New York City area within next 18 months  Facial aesthetics market expected to grow to $4.6 billion by 2018 (18% CAGR) and $9.2 billion by 2020, up from $2.1 billion in 2011  Top two services are Botox Cosmetic injections and soft tissue filler  LABB uses FDA-approved injectable fillers manufactured by top global companies:  Experienced management team  25+ years of beauty industry experience, combined with medical expertise
  • 13.
    13 Trump Tower I 16001Collins Ave, #3202 Sunny Isles Beach, FL 33160 www.joeynewyork.com OTC: JOEY Tel: 305-948-9998 Fax: 305-675-2233 info@joeynewyork.com